As you walk into the Eclectic Artistry Boutique you’re welcomed by bright colors and hit with the unique style Etrenda Jones ...

A new independent academic study examining a form of blood cancer among those who served at Malmstrom Air Force Base, Montana ...

Y-mAbs announces first patient dosed in Phase 1 trial of CD38-SADA pre-targeted radioimmunotherapy for relapsed non-Hodgkin lymphoma. Y-mAbs Therapeutics, Inc. announced that the first patient has ...

has initiated a Phase 1 clinical trial for a novel radioimmunotherapy treatment targeting non-Hodgkin Lymphoma (NHL). The first patient has received the initial protein and imaging doses as part ...

resurrecting the use of IL-2-directed therapy for this rare form of non-Hodgkin lymphoma (NHL). Lymphir – a recombinant fusion protein that combines an IL-2 binding domain with diphtheria toxin ...

Non-Hodgkin lymphoma is a cancer that affects lymphocytes, a type of white blood cells in the lymphatic system. They are generally classified according to the cancer's growth rate as high grade ...

NEW YORK - Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB), a biopharmaceutical company with a strong financial position and current ratio of 4.16, has initiated a Phase 1 clinical trial for a novel ...

Apr. 4, 2025 — A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated ...

Cancer Treatment 101: A Primer for Non-Oncologists Many of your patients are undergoing complicated, multiphase cancer treatments. We all need a basic understanding of what they are facing.